GasGene key facts
as of Oct 2026- Manufacturer of synthetic biology products designed to transform carbon utilisation and support sustainable industry.
- GasGene is valued at approximately $13.8M as of Oct 2026 (last reported valuation).
- It has raised $20.0M; the latest was Early Stage VC ($14.5M) in Feb 2026.
- Notable investors include Qianhai FoF, Zijin Hi-Tech Venture Capital, Tencent Investment, Tianjin Venture Capital, Jiangbei Investment Group — 11 tracked in total.
- Status: Privately Held (backing).
GasGene's last reported valuation, Oct 2023. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch GasGene: the Monday email on marks, rounds and moves
GasGene funding rounds
No funding rounds for GasGene are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs GasGene
11+Membership and data by Private Market View
GasGene valuation
GasGene's last reported valuation was $13.8 million in Oct 2023. No priced round, secondary trade or fund mark has surfaced since.
GasGene investors
11 investors are on record for GasGene, including Qianhai FoF, Zijin Hi-Tech Venture Capital, Tencent Investment and Tianjin Venture Capital.
About GasGene
Manufacturer of synthetic biology products designed to transform carbon utilisation and support sustainable industry. The company's offerings feature engineered Clostridia and anaerobic gas-fermentation technology, enabling customers to benefit from cost-efficient, carbon-negative chemical and protein production, which supports progress toward energy security and carbon neutrality.
- Sector
- Materials and Resources
- HQ
- Nanjing, China
- Founded
- 2023
- Website
- gasgene.com.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.